alexa Abstract | Simultaneous Estimation of Aliskiren and Amlodipine in Tablet Dosage form by UV Spectroscopy

International Journal of Drug Development and Research
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)


Two simple, sensitive, rapid and accurate analytical methods have been developed for the simultaneous of ALISKIREN and AMLODIPINE in marketed formulation of pharmaceutical dosage forms. The Q-analysis based on measurement of absorptivity at 279nm and 289nm (as an isoabsorptive point). The second method developed and validated of simultaneous equation using 279/361nm. ALISKIREN and AMLODIPINE at their respective λmax 279nm and 361nm and at iso absorptive point 289nm show linearity in a concentration range of 20-100μg/ml and 5- 25μg/ml.Recovery studies range from 99.51% for Aliskiren and 99.51% for Amlodipine in case of simultaneous equation method Aliskiren was 100.10% and Amlodipine was 100.47%.

To read the full article Peer-reviewed Article PDF image | Peer-reviewed Full Article image

Author(s): Das Paramita Patel Sandip PP Radhika Subramanyam EVS A Sharbaraya


Aliskiren, Amlodipine, Q-analysis, Simultaneous equation

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version